| P2093 | author name string | Pedro R Cutillas | |
| | Claus Jørgensen | |
| P2860 | cites work | Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis | Q24294864 |
| | Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216 | Q24309035 |
| | The PI3K-PDK1 connection: more than just a road to PKB | Q24531972 |
| | Ultrasensitivity in the mitogen-activated protein kinase cascade | Q24597665 |
| | Genomic screening with RNAi: results and challenges | Q24626537 |
| | AKT/PKB signaling: navigating downstream | Q24657857 |
| | Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS | Q24680943 |
| | The phosphoinositide 3-kinase pathway | Q27860738 |
| | Global, in vivo, and site-specific phosphorylation dynamics in signaling networks | Q27864128 |
| | A global protein kinase and phosphatase interaction network in yeast. | Q27932206 |
| | Synthesis and function of 3-phosphorylated inositol lipids | Q28200755 |
| | Evolution of protein kinase signaling from yeast to man | Q28205635 |
| | Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation | Q28205761 |
| | Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules | Q28256069 |
| | Emergent properties of networks of biological signaling pathways | Q28293858 |
| | PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival | Q28569674 |
| | Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation | Q28594707 |
| | Proteomics data repositories: providing a safe haven for your data and acting as a springboard for further research | Q28748781 |
| | Patterns of somatic mutation in human cancer genomes | Q29547841 |
| | Exploiting the PI3K/AKT pathway for cancer drug discovery | Q29615120 |
| | PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation | Q29615970 |
| | Targets of the cyclin-dependent kinase Cdk1 | Q29616479 |
| | Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer | Q29617440 |
| | Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer | Q29618155 |
| | Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase | Q29620235 |
| | Linear Motif Atlas for Phosphorylation-Dependent Signaling | Q30002322 |
| | NetworKIN: a resource for exploring cellular phosphorylation networks | Q30002344 |
| | Tranche Distributed Repository and ProteomeCommons.org | Q30484716 |
| | Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line | Q31170961 |
| | Cancer proliferation gene discovery through functional genomics. | Q33317743 |
| | Increased confidence in large-scale phosphoproteomics data by complementary mass spectrometric techniques and matching of phosphopeptide data sets | Q33470576 |
| | In-depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immunoaffinity purification and stable isotope dimethyl labeling | Q33598027 |
| | Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs | Q33757668 |
| | Tracing pathway activities with kinase inhibitors and reverse phase protein arrays | Q33764423 |
| | Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma | Q33794491 |
| | Stable isotope-free relative and absolute quantitation of protein phosphorylation stoichiometry by MS | Q33926837 |
| | Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors | Q34005966 |
| | Robustness of cellular functions | Q34348549 |
| | Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins | Q34473545 |
| | STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells | Q40062219 |
| | Quantitative proteomics to study mitogen-activated protein kinases | Q40214560 |
| | Regulation of Raf-Akt Cross-talk | Q40727585 |
| | Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration | Q40900789 |
| | Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. | Q40915594 |
| | PI3K: downstream AKTion blocks apoptosis | Q41351876 |
| | Increased Selectivity, Analytical Precision, and Throughput in Targeted Proteomics | Q42139993 |
| | Positive selection of tyrosine loss in metazoan evolution. | Q42705317 |
| | The synthetic peptide RPRAATF allows specific assay of Akt activity in cell lysates | Q42814981 |
| | Phospho.ELM: a database of phosphorylation sites--update 2008. | Q43032227 |
| | Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells | Q43649346 |
| | MAP kinases: charting the regulatory pathways | Q45270866 |
| | Weak functional constraints on phosphoproteomes | Q46059756 |
| | Quantitative profile of five murine core proteomes using label-free functional proteomics | Q48137615 |
| | A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. | Q51307059 |
| | Drivers and passengers | Q59080774 |
| | Cell-signalling dynamics in time and space | Q34495098 |
| | Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry | Q34694707 |
| | Dynamic modularity in protein interaction networks predicts breast cancer outcome | Q34934057 |
| | Molecular crosstalk between p70S6k and MAPK cell signaling pathways | Q34975063 |
| | Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling | Q34994048 |
| | Cell fate decisions are specified by the dynamic ERK interactome | Q35014377 |
| | Sensitive multiplexed analysis of kinase activities and activity-based kinase identification | Q35086243 |
| | Targeting the PI3K-Akt pathway in human cancer: rationale and promise | Q35571372 |
| | Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks | Q35749545 |
| | Cell signaling pathways as control modules: complexity for simplicity? | Q36099088 |
| | Profiling of UV-induced ATM/ATR signaling pathways. | Q36288898 |
| | KESTREL: a powerful method for identifying the physiological substrates of protein kinases | Q36334959 |
| | The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases | Q36393512 |
| | PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites | Q36482015 |
| | Dissection of the insulin signaling pathway via quantitative phosphoproteomics | Q36497303 |
| | AMP-activated protein kinase signaling in metabolic regulation | Q36528537 |
| | Applying a targeted label-free approach using LC-MS AMT tags to evaluate changes in protein phosphorylation following phosphatase inhibition | Q36837717 |
| | Flying under the radar: the new wave of BCR-ABL inhibitors | Q36939898 |
| | Kinase requirements in human cells: I. Comparing kinase requirements across various cell types | Q36954852 |
| | Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines | Q36954863 |
| | Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle | Q37175187 |
| | Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction | Q37258096 |
| | Global and site-specific quantitative phosphoproteomics: principles and applications | Q37286195 |
| | Targeted therapies in breast cancer: where are we now? | Q37327300 |
| | Analytical strategies for phosphoproteomics | Q37398801 |
| | Challenges and opportunities in defining the essential cancer kinome | Q37422852 |
| | Targeting innate immunity protein kinase signalling in inflammation | Q37502685 |
| | Simplistic pathways or complex networks? | Q37680171 |
| | Approaches and Applications of Quantitative LC-MS for Proteomics and Activitomics | Q37788626 |
| | Overview of Quantitative LC-MS Techniques for Proteomics and Activitomics | Q37788627 |
| | A Self-validating Quantitative Mass Spectrometry Method for Assessing the Accuracy of High-content Phosphoproteomic Experiments | Q39640466 |
| | Quantification of protein kinase activities by LC-MS. | Q39656201 |
| | Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases | Q39663675 |
| | QIKS--Quantitative identification of kinase substrates | Q39729724 |
| | Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines | Q39872411 |
| P4510 | describes a project that uses | mass spectrometry | Q180809 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mass spectrometry | Q180809 |
| P304 | page(s) | 189-199 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Biological signalling activity measurements using mass spectrometry | |
| P478 | volume | 434 | |